Endovascular Treatment for Acute Ischemic Stroke With or Without General Anesthesia: A Matched Comparison. Issue 5 (28th March 2022)

• Record Type: Journal Article
• Authors: Wagner, Benjamin; Lorscheider, Johannes; Wiencierz, Andrea; Blackham, Kristine; Psychogios, Marios; Bolliger, Daniel; De Marchis, Gian Marco; Engelter, Stefan T.; Lyrer, Philippe; Wright, Patrick R.; Fischer, Urs; Mordasini, Pasquale; Nannoni, Stefania; Puccinelli, Francesco; Kahles, Timo; Bianco, Giovanni; Carrera, Emmanuel; Luft, Andreas R.; Cereda, Carlo W.; Kägi, Georg; Weber, Johannes; Nedeltchev, Krassen; Michel, Patrik; Gralla, Jan; Arnold, Marcel; Bonati, Leo H.
• Is Part Of: Stroke. Volume 53:Issue 5(2022)
• Page Start: 1520
• Page End: 1529
• Publication Date: 2022-03-28
• Subjects: anesthesia, general -- intracranial hemorrhage -- ischemic stroke -- propensity score -- registries; Cerebrovascular disease -- Periodicals; Cerebral circulation -- Periodicals; 616.81
• DOI: 10.1161/STROKEAHA.121.034934
• Languages: English
• ISSNs: 0039-2499

Abstract

Abstract : Background: Endovascular treatment in large artery occlusion stroke reduces disability. However, the impact of anesthesia type on clinical outcomes remains uncertain. Methods: We compared consecutive patients in the Swiss Stroke Registry with anterior circulation stroke receiving endovascular treatment with or without general anesthesia (GA). The primary outcome was disability on the modified Rankin Scale after 3 months, analyzed with ordered logistic regression. Secondary outcomes included dependency or death (modified Rankin Scale score ≥ 3), National Institutes of Health Stroke Scale after 24 hours, symptomatic intracranial hemorrhage with ≥ 4 points worsening on National Institutes of Health Stroke Scale within 7 days, and mortality. Coarsened exact matching and propensity score matching were performed to adjust for indication bias. Results: One thousand two hundred eighty-four patients (GA: n=851, non-GA: n=433) from 8 Stroke Centers were included. Patients treated with GA had higher modified Rankin Scale scores after 3 months than patients treated without GA, in the unmatched (odds ratio [OR], 1.75 [1.42–2.16]; P <0.001), the coarsened exact matching (n=332–524, using multiple imputations of missing values; OR, 1.60 [1.08–2.36]; P =0.020), and the propensity score matching analysis (n=568; OR, 1.61 [1.20–2.15]; P =0.001). In the coarsened exact matching analysis, there were no significant differences in National Institutes of Health Stroke Scale after 1 day (estimated coefficient 2.61 [0.59–4.64]), symptomatic intracranial hemorrhage (OR, 1.06 [0.30–3.75]), dependency or death (OR, 1.42 [0.91–2.23]), or mortality (OR, 1.65 [0.94–2.89]). In the propensity score matching analysis, National Institutes of Health Stroke Scale after 24 hours (estimated coefficient, 3.40 [1.76–5.04]), dependency or death (OR, 1.49 [1.07–2.07]), and mortality (OR, 1.65 [1.11–2.45]) were higher in the GA group, whereas symptomatic intracranial hemorrhage did not differ significantly (OR, 1.77 [0.73–4.29]). Conclusions: This large study showed worse functional outcome after endovascular treatment of anterior circulation stroke with GA than without GA in a real-world setting. This finding appears to be independent of known differences in patient characteristics between groups.